LobbyingBioprincipia lobbying by quarter
Bioprincipia's latest lobbying report covers Q1 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $30K. Its first report covers Q2 2025; the issues it reports most are Energy/Nuclear and Trade (Domestic & Foreign).
Bioprincipia
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $30K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $20K | 1 |
| Q3 2025 | $60K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Energy and nuclear$55K · 3 reports
- Trade$55K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES3 reports
- SENATE3 reports
- White House Office2 reports
- Energy, Dept of1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Holland & Knight | $110K | 4 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 04/05for Q1 | Holland & Knight | Under $5,000 |
| 01/11for Q4 2025 | Holland & Knight | $30K |
| 25/10/18for Q3 2025 | Holland & Knight | $60K |
| 25/07/11for Q2 2025 | Holland & Knight | $20K |
| 25/07/08for Q2 2025 | Holland & Knight | Under $5,000 |